SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-008248
Filing Date
2020-01-29
Accepted
2020-01-29 20:08:53
Documents
1
Period of Report
2020-01-28

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 7939
  Complete submission text file 0001104659-20-008248.txt   9329
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 7TH AVENUE NE ST. PETERSBURG FL 33701
Business Address
White Mark K. (Reporting) CIK: 0001786183 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39202 | Film No.: 20559536